
### [Orphanet:156601](http://www.orpha.net/ORDO/Orphanet_156601)
**Label:** Rare genetic hepatic disease

**Subclasses:** [Orphanet:79124](http://www.orpha.net/ORDO/Orphanet_79124) (Hepatic veno-occlusive disease-immunodeficiency syndrome), [Orphanet:1414](http://www.orpha.net/ORDO/Orphanet_1414) (Cholestasis-lymphedema syndrome), [Orphanet:276405](http://www.orpha.net/ORDO/Orphanet_276405) (Hyperbiliverdinemia), [Orphanet:2312](http://www.orpha.net/ORDO/Orphanet_2312) (Transient familial neonatal hyperbilirubinemia), 

**Corr. equiv. classes:** [Orphanet:2312](http://www.orpha.net/ORDO/Orphanet_2312), [Orphanet:276405](http://www.orpha.net/ORDO/Orphanet_276405), [OMIM:214900](http://purl.obolibrary.org/obo/OMIM_214900), [OMIM:614156](http://purl.obolibrary.org/obo/OMIM_614156), [OMIM:237900](http://purl.obolibrary.org/obo/OMIM_237900), [Orphanet:79124](http://www.orpha.net/ORDO/Orphanet_79124), [Orphanet:1414](http://www.orpha.net/ORDO/Orphanet_1414), [OMIM:235550](http://purl.obolibrary.org/obo/OMIM_235550), 

**Class expressions from DL-Learner:**

- [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 62.50%
- [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 62.50%
- [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 62.50%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 62.50%
- [HP:0001004](http://purl.obolibrary.org/obo/HP_0001004) (Lymphedema) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 62.50%
- [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 62.50%
- [HP:0001394](http://purl.obolibrary.org/obo/HP_0001394) (Cirrhosis) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 62.50%
- [HP:0001394](http://purl.obolibrary.org/obo/HP_0001394) (Cirrhosis) and [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 62.50%
- [HP:0001394](http://purl.obolibrary.org/obo/HP_0001394) (Cirrhosis) and [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 62.50%
- [HP:0001394](http://purl.obolibrary.org/obo/HP_0001394) (Cirrhosis) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 62.50%
- [HP:0001004](http://purl.obolibrary.org/obo/HP_0001004) (Lymphedema) and [HP:0001394](http://purl.obolibrary.org/obo/HP_0001394) (Cirrhosis) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 62.50%
- [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) and [HP:0001394](http://purl.obolibrary.org/obo/HP_0001394) (Cirrhosis) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 62.50%
- [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and (not ([HP:0025155](http://purl.obolibrary.org/obo/HP_0025155) (Abnormality of hepatobiliary system physiology))) 62.50%
- [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and (not ([HP:0001410](http://purl.obolibrary.org/obo/HP_0001410) (Decreased liver function))) 62.50%
- [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and (not ([HP:0001399](http://purl.obolibrary.org/obo/HP_0001399) (Hepatic failure))) 62.50%


